Journal of Critical Care
Volume 23, Issue 1 , Pages 18-26 , March 2008

Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: Prevalence, incidence, risk factors, and outcomes

  • Chris M. Parker, MD, MSc

      Affiliations

    • Department of Medicine, Queen's University, Kingston, Ontario, Canada K7L 2V7
    • ,
  • Jim Kutsogiannis, MD, MHS

      Affiliations

    • Department of Critical Care, University of Alberta, Edmonton, Alberta, Canada T6G 2R3
    • ,
  • John Muscedere, MD

      Affiliations

    • Department of Medicine, Queen's University, Kingston, Ontario, Canada K7L 2V7
    • ,
  • Deborah Cook, MD, MSc

      Affiliations

    • Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada L8N 3Z5
    • ,
  • Peter Dodek, MD, MHSc

      Affiliations

    • Center for Health Evaluation and Outcome Sciences, University of British Columbia, Vancouver, British Columbia, Canada V6Z 1Y6
    • ,
  • Andrew G. Day, MSc

      Affiliations

    • Clinical Evaluation Research Unit, Kingston General Hospital, Kingston, Ontario, Canada K7L 2V7
    • ,
  • Daren K. Heyland, MD, MSc

      Affiliations

    • Department of Medicine, Queen's University, Kingston, Ontario, Canada K7L 2V7
    • Clinical Evaluation Research Unit, Kingston General Hospital, Kingston, Ontario, Canada K7L 2V7
    • Corresponding Author InformationCorresponding author. Kingston General Hospital, Kingston, Ontario, Canada K7L 2V7. Tel.: +1 613 549 6666x3339; fax: +1 613 548 1351.
    • ,
  • for the Canadian Critical Care Trials Group

References 

  1. Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002;122:2115–2121
  2. Heyland DK, Cook DJ, Griffith L, et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Care Trials Group. Am J Respir Crit Care Med. 1999;159:1249–1256
  3. Fagon JY, Chastre J, Hance AJ, et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med. 1993;94:281–288
  4. Safdar N, Dezfulian C, Collard HR, et al. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med. 2005;33:2184–2193
  5. American Thoracic Society . Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388–416
  6. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165:867–903
  7. Combes A, Luyt CE, Fagon JY, et al. Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia. Crit Care Med. 2007;35:146–154
  8. Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest. 1998;113:412–420
  9. Iregui M, Ward S, Sherman G, et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest. 2002;122:262–268
  10. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med. 1998;157:531–539
  11. Rello J, Allegri C, Rodriguez A, et al. Risk factors for ventilator-associated pneumonia by Pseudomonas aeruginosa in the presence of recent antibiotic exposure. Anesthesiology. 2006;105:709–714
  12. The Canadian Critical Care Trials Group. A Randomized trial of diagnostic techniques for ventilator-associated pneumonia. New Engl J Med. 2006;355:2619–2630
  13. Hosmer DJ, Lemeshow S. Applied logistic regression. New York (NY): John Wiley and Sons; 1989;
  14. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239–241
  15. Drakulovic MB, Bauer TT, Torres A, et al. Initial bacterial colonization in patients admitted to a respiratory intensive care unit: bacteriological pattern and risk factors. Respiration. 2001;68:58–66
  16. Olsen B, Weinstein RA, Nathan C, et al. Epidemiology of endemic Pseudomonas aeruginosa: why infection control efforts have failed. J Infect Dis. 1984;150:808–816
  17. de Latorre FJ, Pont T, Ferrer A, et al. Pattern of tracheal colonization during mechanical ventilation. Am J Respir Crit Care Med. 1995;152:1028–1033
  18. Ewig S, Torres A, El-Ebiary M, et al. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury: incidence, risk factors, and association with ventilator-associated pneumonia. Am J Respir Crit Care Med. 1999;159:188–198
  19. Heyland DK, Cook DJ, Schoenfeld PS, et al. The effect of acidified enteral feeds on gastric colonization in critically ill patients: results of a multicenter randomized trial. Crit Care Med. 1999;27:2399–2406
  20. Sirvent JM, Torres A, Vidaur L, et al. Tracheal colonization within 24 h of intubation in patients with head trauma: risk factor for developing early-onset ventilator-associated pneumonia. Intensive Care Med. 2000;26:1369–1372
  21. Johanson WJ, Pierce AK, Sanford JP, et al. Nosocomial respiratory infections with Gram-negative bacilli: the significance of colonization of the respiratory tract. Ann Intern Med. 1972;77:701–706
  22. Rello J, Ausina V, Ricart M, et al. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest. 1993;104:1230–1235
  23. Kollef MH. Ventilator-associated pneumonia. A multivariate analysis. JAMA. 1993;270:1965–1970
  24. Rello J, Diaz E, Roque M, et al. Risk factors for developing pneumonia within 48 hours of intubation. Am J Respir Crit Care Med. 1999;159:1742–1746
  25. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med. 1998;129:433–440
  26. George DL, Falk PS, Wunderink RG, et al. Epidemiology of ventilator-acquired pneumonia based on protected bronchoscopic sampling. Am J Respir Crit Care Med. 1998;158:1839–1847
  27. Porzecanski I, Bowton DL. Diagnosis and treatment of ventilator-associated pneumonia. Chest. 2006;130:597–604
  28. Fagon JY, Chastre J, Domart Y, et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis. 1989;139:877–884
  29. Kollef MH, Silver P, Murphy DM, et al. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest. 1995;108:1655–1662
  30. Combes A, Luyt CE, Fagon JY, et al. Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia. Am J Respir Crit Care Med. 2004;170:786–792
  31. Combes A, Luyt CE, Fagon JY, et al. Impact of piperacillin resistance on the outcome of Pseudomonas ventilator-associated pneumonia. Intensive Care Med. 2006;32:1970–1978
  32. Rello J, Rue M, Jubert P, et al. Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent. Crit Care Med. 1997;25:1862–1867
  33. Fagon J, Chastre J, Hance AJ, et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med. 1993;94:281–288
  34. French GL, Cheng AF, Ling JM, et al. Hong Kong strains of methicillin-resistant and methicillin-sensitive Staphylococcus aureus have similar virulence. J Hosp Infect. 1990;15:117–125
  35. Kollef MH, Sherman G, Ward S, et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462–474
  36. The Canadian Critical Care Trials Group . A randomized trial of combination vs. monotherapy for ventilator-associated pneumonia. Crit Care Med. 2008;

PII: S0883-9441(08)00032-4

doi: 10.1016/j.jcrc.2008.02.001

Journal of Critical Care
Volume 23, Issue 1 , Pages 18-26 , March 2008

Article Tools

* Image Usage & Resolution